Mabion S.A.

WSE:MAB Stock Report

Market Cap: zł162.6m

Mabion Future Growth

Future criteria checks 4/6

Mabion is forecast to grow earnings and revenue by 37.1% and 9% per annum respectively. EPS is expected to grow by 3.2% per annum. Return on equity is forecast to be -6.6% in 3 years.

Key information

37.1%

Earnings growth rate

3.23%

EPS growth rate

Biotechs earnings growth21.0%
Revenue growth rate9.0%
Future return on equity-6.60%
Analyst coverage

Low

Last updated29 Apr 2025

Recent future growth updates

Recent updates

Mabion S.A.'s (WSE:MAB) Revenues Are Not Doing Enough For Some Investors

Apr 15
Mabion S.A.'s (WSE:MAB) Revenues Are Not Doing Enough For Some Investors

Revenues Working Against Mabion S.A.'s (WSE:MAB) Share Price Following 29% Dive

Dec 22
Revenues Working Against Mabion S.A.'s (WSE:MAB) Share Price Following 29% Dive

Some May Be Optimistic About Mabion's (WSE:MAB) Earnings

Nov 06
Some May Be Optimistic About Mabion's (WSE:MAB) Earnings

Investors Don't See Light At End Of Mabion S.A.'s (WSE:MAB) Tunnel And Push Stock Down 30%

Nov 05
Investors Don't See Light At End Of Mabion S.A.'s (WSE:MAB) Tunnel And Push Stock Down 30%

Mabion's (WSE:MAB) Shareholders May Want To Dig Deeper Than Statutory Profit

Apr 24
Mabion's (WSE:MAB) Shareholders May Want To Dig Deeper Than Statutory Profit

Mabion S.A. (WSE:MAB) Shares Fly 30% But Investors Aren't Buying For Growth

Nov 28
Mabion S.A. (WSE:MAB) Shares Fly 30% But Investors Aren't Buying For Growth

Industry Analysts Just Made A Huge Upgrade To Their Mabion S.A. (WSE:MAB) Revenue Forecasts

Jun 02
Industry Analysts Just Made A Huge Upgrade To Their Mabion S.A. (WSE:MAB) Revenue Forecasts

Does Mabion (WSE:MAB) Have A Healthy Balance Sheet?

Jul 09
Does Mabion (WSE:MAB) Have A Healthy Balance Sheet?

Mabion (WSE:MAB) Is Posting Solid Earnings, But It Is Not All Good News

Jun 04
Mabion (WSE:MAB) Is Posting Solid Earnings, But It Is Not All Good News

Is Mabion (WSE:MAB) Using Too Much Debt?

Dec 22
Is Mabion (WSE:MAB) Using Too Much Debt?

Mabion S.A. (WSE:MAB) Shares Could Be 47% Below Their Intrinsic Value Estimate

Sep 11
Mabion S.A. (WSE:MAB) Shares Could Be 47% Below Their Intrinsic Value Estimate

How Much Of Mabion S.A. (WSE:MAB) Do Institutions Own?

Feb 24
How Much Of Mabion S.A. (WSE:MAB) Do Institutions Own?

Earnings and Revenue Growth Forecasts

WSE:MAB - Analysts future estimates and past financials data (PLN Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/2027693-19112
12/31/202651-17-17-123
12/31/202531-41-32-271
12/31/202469-62840N/A
9/30/2024111101547N/A
6/30/2024140371255N/A
3/31/202414642-414N/A
12/31/202315241-40-2N/A
9/30/2023148583462N/A
6/30/2023157423352N/A
3/31/2023165326984N/A
12/31/2022164232239N/A
9/30/202215645-67-46N/A
6/30/202211734-52-24N/A
3/31/20227526-109-75N/A
12/31/2021362-65-33N/A
9/30/20212-51-38-20N/A
6/30/20212-45-58-49N/A
3/31/2021N/A-53-13-10N/A
12/31/2020N/A-56-39-35N/A
9/30/2020N/A-55-40-35N/A
6/30/2020N/A-63-35-30N/A
3/31/2020N/A-69-37-31N/A
12/31/2019N/A-64-43-34N/A
9/30/2019N/A-65-42-31N/A
6/30/2019N/A-59-36-24N/A
3/31/2019N/A-70-44-34N/A
12/31/2018N/A-69-46-39N/A
9/30/2018N/A-72N/A-42N/A
6/30/2018N/A-74N/A-62N/A
3/31/2018N/A-59N/A-61N/A
12/31/2017N/A-58N/A-54N/A
9/30/2017N/A-56N/A-35N/A
6/30/2017N/A-57N/A-24N/A
3/31/2017N/A-59N/A-26N/A
12/31/2016N/A-56N/A-15N/A
9/30/20160-77N/A-36N/A
6/30/20160-65N/A-44N/A
3/31/20163-51N/A-30N/A
12/31/20153-43N/A-32N/A
9/30/20153-6N/A-29N/A
6/30/20153-5N/A-24N/A
3/31/20151-5N/A-30N/A
12/31/20141-4N/A-24N/A
9/30/20141-4N/A-20N/A
6/30/20140-4N/A-26N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MAB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (4.5%).

Earnings vs Market: MAB is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: MAB is expected to become profitable in the next 3 years.

Revenue vs Market: MAB's revenue (9% per year) is forecast to grow faster than the Polish market (4.7% per year).

High Growth Revenue: MAB's revenue (9% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: MAB is forecast to be unprofitable in 3 years.

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/22 05:54
End of Day Share Price 2025/05/22 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Mabion S.A. is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kamil KliszczBiuro maklerskie mBanku
Beata Szparaga-WasniewskaBiuro maklerskie mBanku
Pawel SugalskiING Groep NV